Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling.

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice

Volumn 1, Issue 2, 2001, Pages 101-110

  Speiser, Phyllis W ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 21 MONOOXYGENASE;

CONGENITAL ADRENAL HYPERPLASIA; ENZYMOLOGY; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; GENOTYPE; HUMAN; METABOLISM; METHODOLOGY; MUTATION; PHENOTYPE; REVIEW; STATISTICS;

ADRENAL HYPERPLASIA, CONGENITAL; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HUMANS; MUTATION; PHENOTYPE; STEROID 21-HYDROXYLASE;

EID: 0035552469     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200101020-00003     Document Type: Review

References (74)